Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This clinical trial is designed to evaluate the impact of the addition of NC-6004 to
gemcitabine in the treatment of patients with locally advanced or metastatic pancreatic
cancer in Asian countries.